For those who have girly "issues"....I did BIG TIME! For YEARS!
I was given every kind of estrogen they made over several years.. and I only got MUCH worse! Nearly dead... or wishing I was.
I accidently stumbled across using progestrone to help myself.. and it worked WONDERS for me.
Now.. when you are pregnant.. you have more progestrone for some reason.. and less estrogen. Don't ask me more details than that.. I am not a girl thing expert... I was simply born with one.
Anyhow..
I improved BIG TIME when using progestrone.. as I have written about many times here.
Look at this abstract... TRY to forget the authors if you can..
But look at the message it is saying.
Basically... the mice on progestrone or who were pregnant had LESS damage and problems with Lyme.
Pass this along to your LLMD... please!
J Immunol. 2001 Jun 15;166(12):7404-9.
Gestational attenuation of Lyme arthritis is mediated by progesterone and IL-4.
Moro MH, Bjornsson J, Marietta EV, Hofmeister EK, Germer JJ, Bruinsma E, David CS, Persing DH.
Department of Immunology, Mayo Foundation, Rochester, MN 55905, USA.
Infection of different strains of laboratory mice with the agent of Lyme disease, Borrelia burgdorferi, results in arthritis, the severity of which has been correlated with the dominance of Th1 cytokines.
In this study, we demonstrate that changes in B. burgdorferi-specific immunologic responses associated with pregnancy can alter the outcome of Lyme arthritis in mice.
Whereas nonpregnant female C3H mice consistently developed severe Lyme arthritis, pregnant mice had a marked reduction in arthritis severity that was associated with a slight reduction in IFN-gamma and markedly increased levels of IL-4 production by B. burgdorferi-specific T cells.
Similar reductions in arthritis severity and patterns of cytokine production were observed in nonpregnant, progesterone-implanted mice.
Ab neutralization of IL-4 in progesterone-implanted mice resulted in severe arthritis.
Our results are consistent with the known shift toward Th2 cytokine expression at the maternal-fetal interface, and are the first to show a pregnancy-related therapeutic effect in an infectious model.
PMID: 11390492 [PubMed - indexed for MEDLINE]